The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Nov. 03, 2011
Applicants:

Carl A. Gregory, Temple, TX (US);

Ulf C. Krause, Temple, TX (US);

Bret H. Clough, Temple, TX (US);

Inventors:

Carl A. Gregory, Temple, TX (US);

Ulf C. Krause, Temple, TX (US);

Bret H. Clough, Temple, TX (US);

Assignee:

THE TEXAS A&M UNIVERSITY SYSTEM, College Station, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A01N 65/00 (2009.01); A61K 35/28 (2015.01); C12N 5/0775 (2010.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); C12N 5/0663 (2013.01); A61K 2035/124 (2013.01); C12N 2501/385 (2013.01); C12N 2501/415 (2013.01);
Abstract

Materials and methods for preparing mesenchymal stem cells are described such that the mesenchymal stem cells remain for a longer period of time than would normally be found at a site of tissue healing. The mesenchymal stem cells are pretreated to exhibit osteogenic characteristics and, when combined with extracellular matrix components produced from the pretreated cells, improve tissue healing. Co-administration of the pretreated cells and their secreted extracellular matrix components at an injured site or defect allowed the mesenchymal stem cells to co-localize at or near the injured or defect site for a longer period. The combination improves overall repair of the tissue by extending the retention signal of mesenchymal stem cells. A three-dimensional scaffold containing the pretreated cells with or without addition of the secreted extracellular matrix is also described. The conditioned scaffold is suitable for use in vivo and may be preserved cryogenically prior to use.


Find Patent Forward Citations

Loading…